| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 197.404 | 277.421 | 152.049 | 47.897 | 0 | - | - | - | - | - |
| Total Income - EUR | 210.235 | 289.604 | 172.242 | 75.937 | 14.249 | - | - | - | - | - |
| Total Expenses - EUR | 271.622 | 291.538 | 179.694 | 109.432 | 48.073 | - | - | - | - | - |
| Gross Profit/Loss - EUR | -61.387 | -1.934 | -7.452 | -33.495 | -33.823 | - | - | - | - | - |
| Net Profit/Loss - EUR | -61.387 | -1.934 | -8.970 | -34.152 | -33.888 | - | - | - | - | - |
| Employees | 10 | 9 | 8 | 5 | 3 | - | - | - | - | - |
Check the financial reports for the company - Nugamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 23.398 | 19.263 | 15.414 | 8.780 | 6.815 | - | - | - | - | - |
| Current Assets | 91.739 | 95.346 | 75.344 | 73.010 | 78.547 | - | - | - | - | - |
| Inventories | 59.710 | 62.583 | 45.143 | 58.212 | 64.582 | - | - | - | - | - |
| Receivables | 28.686 | 28.921 | 17.777 | 14.801 | 13.661 | - | - | - | - | - |
| Cash | 3.343 | 3.841 | 12.425 | -2 | 303 | - | - | - | - | - |
| Shareholders Funds | -167.300 | -167.528 | -173.663 | -204.628 | -234.554 | - | - | - | - | - |
| Social Capital | 225 | 223 | 219 | 215 | 211 | - | - | - | - | - |
| Debts | 284.946 | 283.717 | 266.007 | 287.985 | 319.915 | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Nugamed Srl